May 15, 2013

A new treatment for late-stage prostate cancer has received approval from the Food and Drug Administration.

September 28, 2012

Drug maker OncoGenex Pharmaceuticals has started its third late-stage clinical trial of a drug for treating a type of lung cancer.

June 19, 2012

Pfizer announced the results of its late-stage clinical trial of Xalkori (crizotinib).

August 23, 2011

The Food and Drug Administration has approved a chemotherapy drug made by Sandoz, the drug maker said Tuesday.

April 29, 2011

The Food and Drug Administration has approved a new treatment for prostate cancer made by Johnson & Johnson.

April 26, 2011

Hospira had net sales of $1 billion during first quarter 2011, the generic drug maker said Tuesday.

March 11, 2011

While failing to improve overall survival, an investigational treatment for non-small cell lung cancer made by Sanofi-Aventis and Regeneron Pharmaceuticals did keep the disease from worsening and, overall, caused patients to respond to treatment, according to results of a late-stage clinical trial.

March 10, 2011

Hospira has received approval from the Food and Drug Administration for a generic cancer treatment.

September 30, 2010

Data published in the latest issue of medical journal The Lancet showed that a recently...

September 29, 2010

Teva Pharmaceutical Industries and OncoGenex Pharmaceuticals have started a late-stage clinical trial of an investigative...

August 5, 2010

The Food and Drug Administration has approved a new formulation of a chemotherapy drug made...

June 16, 2010

The Food and Drug Administration has approved a new treatment for advanced prostate cancer, the...

March 11, 2010

A late-stage clinical trial of a Genentech drug for men with late-stage prostate cancer has...

March 11, 2010

Two clinical trials of a Pfizer drug for treating advanced breast cancer have failed, Pfizer...